Valuation: IRADIMED CORPORATION

Market Cap 1.25B 1.1B 1.02B 935M 1.77B 119B 1.81B 12.13B 4.74B 58.66B 4.69B 4.59B 203B P/E 2026 *
51.1x
P/E 2027 * 45.1x
Enterprise Value 1.25B 1.1B 1.02B 935M 1.77B 119B 1.81B 12.13B 4.74B 58.66B 4.69B 4.59B 203B EV / Sales 2026 *
13.7x
EV / Sales 2027 * 12.4x
Free-Float
64.8%
Yield 2026 *
-
Yield 2027 * -
1 day+0.50%
1 week-3.25%
Current month+2.23%
1 month+4.37%
3 months+4.59%
6 months-0.21%
Current year+0.42%
1 week 95.12
Extreme 95.12
102.99
1 month 89.69
Extreme 89.69
102.99
Current year 76.95
Extreme 76.95
107.9
1 year 55.11
Extreme 55.1093
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 27/05/2020
Director of Finance/CFO 64 19/06/2022
Chief Tech/Sci/R&D Officer - 31/12/2019
Director TitleAgeSince
Chairman 72 15/06/2020
Director/Board Member 70 31/12/2018
Director/Board Member 73 31/12/2013
Date Insider Type Main position Quantity % Market Cap.
06-19Fiscal year

Chief Financial Officer

13,911 0.1088%
06-03Sell

Director

-3,000 0.0235%
05-31Sell

Chief Executive Officer

-2,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
+0.50%-3.25%+69.69%+110.22% 1.24B
-0.56%+3.30%-13.63%-23.51% 13.18B
-8.01%-18.84%+53.00%-3.96% 4.59B
+0.58%-2.56%-33.90%-61.77% 1.2B
-1.66%-1.47%-38.67%-47.05% 1.13B
0.00%-5.30%-47.13% - 880M
-8.91%-12.13%+128.43%+118.88% 615M
+3.84%-14.56%+36.11% - 299M
-1.34%-2.77%-54.66%+218.50% 263M
-2.60%+27.29%+12.52%+45.78% 144M
Average -1.82%-1.11%+11.17%+44.64% 2.35B
Weighted average by Cap. -2.11%-0.71%+4.31%-8.10%

Financials

2026 *2027 *
Net sales 91.2M 80.12M 74.29M 68.31M 129M 8.72B 132M 886M 346M 4.28B 342M 335M 14.81B 101M 88.64M 82.19M 75.58M 143M 9.65B 146M 980M 383M 4.74B 379M 371M 16.39B
Net income 24.55M 21.57M 20M 18.39M 34.74M 2.35B 35.49M 238M 93.26M 1.15B 92.18M 90.17M 3.99B 27.8M 24.42M 22.65M 20.82M 39.34M 2.66B 40.19M 270M 106M 1.31B 104M 102M 4.52B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
13/07/26 US$97.69 +0.50% 136,390
10/07/26 US$97.20 -0.86% 88,908
09/07/26 US$98.04 +1.80% 104,005
08/07/26 US$96.31 -3.92% 275,940
07/07/26 US$100.24 -2.01% 113,717
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
97.69USD
Average target price
118.00USD
Spread / Average Target
+20.79%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock